172 related articles for article (PubMed ID: 1549677)
1. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
Braffman BH; Bilaniuk LT; Naidich TP; Altman NR; Post MJ; Quencer RM; Zimmerman RA; Brody BA
Radiology; 1992 Apr; 183(1):227-38. PubMed ID: 1549677
[TBL] [Abstract][Full Text] [Related]
2. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
Jensen MC; Brant-Zawadzki M
AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
[TBL] [Abstract][Full Text] [Related]
3. Routine use of gadopentetate dimeglumine in cranial MR imaging of patients with AIDS.
Elster AD
AJR Am J Roentgenol; 1993 Sep; 161(3):680-1. PubMed ID: 8352135
[No Abstract] [Full Text] [Related]
4. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
5. Application of magnetization transfer imaging for intracranial lesions of tuberous sclerosis.
Jeong MG; Chung TS; Coe CJ; Jeon TJ; Kim DI; Joo AY
J Comput Assist Tomogr; 1997; 21(1):8-14. PubMed ID: 9022761
[TBL] [Abstract][Full Text] [Related]
6. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
7. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
8. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast.
Elster AD; King JC; Mathews VP; Hamilton CA
Radiology; 1994 Feb; 190(2):541-6. PubMed ID: 8284413
[TBL] [Abstract][Full Text] [Related]
9. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
Mirowitz SA; Shady KL
AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
[TBL] [Abstract][Full Text] [Related]
10. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
Myhr G; Rinck PA; Børseth A
Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
[TBL] [Abstract][Full Text] [Related]
11. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
[TBL] [Abstract][Full Text] [Related]
12. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
[TBL] [Abstract][Full Text] [Related]
13. [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
Higer HP; Just M; Grigat M; Meindl S; Jungke M; Bielke G; Pedrosa P; Kunze S; Voth D
Rofo; 1988 Mar; 148(3):307-13. PubMed ID: 2832897
[TBL] [Abstract][Full Text] [Related]
14. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.
Maeda M; Itoh S; Kimura H; Iwasaki T; Hayashi N; Yamamoto K; Ishii Y; Kubota T
Radiology; 1993 Oct; 189(1):233-8. PubMed ID: 8372199
[TBL] [Abstract][Full Text] [Related]
15. Is there any role for gadopentetate dimeglumine administration when searching for mesial temporal sclerosis in patients with seizures?
Bronen RA
AJR Am J Roentgenol; 1995 Feb; 164(2):503. PubMed ID: 7839999
[No Abstract] [Full Text] [Related]
16. Pre- and postcontrast MR studies in tuberous sclerosis.
Wippold FJ; Baber WW; Gado M; Tobben PJ; Bartnicke BJ
J Comput Assist Tomogr; 1992; 16(1):69-72. PubMed ID: 1729309
[TBL] [Abstract][Full Text] [Related]
17. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
Mihara F; Gupta KL; Righi AM
Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
[TBL] [Abstract][Full Text] [Related]
18. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC
Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317
[TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images.
Sherman JL; Stern BJ
AJR Am J Roentgenol; 1990 Dec; 155(6):1293-301. PubMed ID: 2122683
[TBL] [Abstract][Full Text] [Related]
20. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
